Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms
Clinical trial NCT04509167 · COMPLETED
Trial details
- NCT number
- NCT04509167
- Sponsor
- Instituto de Medicina Regenerativa
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2022-06-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.